Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.
Lei ZhangJunfeng ShiYue-Song PanZi-Xiao LiHongyi YanChelsea LiuWei LvXia MengYong-Jun WangPublished in: Stroke and vascular neurology (2021)
Persistence in secondary prevention medications, especially in all classes of medications prescribed by the physician, was associated with lower hazard of recurrent stroke, composite events, all-cause death and lower odds of disability in patients with acute ischaemic stroke or TIA.